Adult hemodialysis patients Urological and Genital Diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Hemodialysis two or three times a week 2. Age > 18 years 3. No previous exercise program participation
Exclusion criteria
Exclusion criteria: 1. Limb amputation 2. Hospitalization in the last 3 months 3. One or less hemodialysis session a week 4. Severe effort angina (CC3) or stage 4 of the New York Heart Association (NYHA) classification scale of heart failure 5. Pregnancy 6. Severe dyspnoea 7. Femoral fistula 8. Arrhythmias 9. Precordial pain 10. Orthopaedic or neurological compromises or cognitive alterations affecting study participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantity of muscle mass: 1. Indicators of muscle mass using anthropometry, measured at baseline, 3-months, and 6-months: 1.1 Mid-arm muscle circumference: mid-arm circumference – (p x triceps skinfold thickness) 1.2 Bone-free arms muscle area: males = [(midarm circumference (cm) - p x triceps (cm)]2/4 p) – 10 females = [(midarm circumference (cm) - p x triceps (cm)]2/4 p) - 6.5 2. Mid-thigh cross-sectional area of muscle mass measured with computed tomography. Quality of muscle mass: 3. Intramuscular lipid infiltration with computed tomography, measured at baseline and at six months. 4. Physical function tests, measured at baseline, 3-months, and 6-months: 4.1 Sit to stand test: To move from a sitting position to a standing position on a 42cm high chair as quick as possible, for ?ve times. 4.2 Time up and go test: measures the time in seconds for a patient to rise from a standard armchair, walk 3 meters, turn around, and return and sit down again. 4.3 Six-minute walk test: To walk back and forth along a 22 m course (two 10-m straight lines connected by two 1-m curves) in a corridor for 6 min. We are going to use the protocol of the American Thoracic Society. Subjects are allowed to rest in case of fatigue or pain, and to resume when possible | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Serum concentrations of myostatin by ELISA, measured at baseline and at six months. 2. Quality of life of patients using the SF-36 KDQOL scale, measured at baseline and at six months. 3. Biochemical indicators of nutritional status (albumin, creatinine, total lymphocyte count and cholesterol) before and after the intervention, measured at baseline and at six months. 4. Dietary indicators of nutritional status (protein and energy intake) before and after the intervention, measured at baseline and at six months. 5. Percentage of patients with protein-energy wasting before and after the intervention | — |
Countries
Mexico